Treatment with Allopurinol is Associated with Lower Risk of Acute Kidney Injury in Patients with Gout: A Retrospective Analysis of a Nested Cohort

Por Perez-Ruiz, Fernando
Publicado no Rheumatol Ther (2017)

Improving adherence to gout therapy: an expert review

Por Perez-Ruiz, Fernando, Desideri, Giovambattista
Publicado no Ther Clin Risk Manag (2018)

A Review of Uric Acid, Crystal Deposition Disease, and Gout

Por Perez-Ruiz, Fernando, Dalbeth, Nicola, Bardin, Tomas
Publicado no Adv Ther (2014)

Hyperuricaemia with deposition: latest evidence and therapeutic approach

Por Perez-Ruiz, Fernando, Marimon, Estibaliz, Chinchilla, Sandra P.
Publicado no Ther Adv Musculoskelet Dis (2015)

Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout

Por Khanna, Puja P., Perez-Ruiz, Fernando, Maranian, Paul, Khanna, Dinesh
Publicado em 2011

High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?

Por Perez-Ruiz, Fernando, Perez-Herrero, Nuria, Richette, Pascal, Stack, Austin G.
Publicado no Rheumatol Ther (2020)

Gout. Imaging of gout: findings and utility

Por Perez-Ruiz, Fernando, Dalbeth, Nicola, Urresola, Aranzazu, de Miguel, Eugenio, Schlesinger, Naomi
Publicado em 2009

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol

Por Perez-Ruiz, Fernando, Sundy, John S, Miner, Jeffrey N, Cravets, Matthew, Storgard, Chris
Publicado no Ann Rheum Dis (2016)

Computational Lexical Analysis of the Language Commonly Used to Describe Gout

Por Lawrence Edwards, N., Malouf, Robert, Perez‐Ruiz, Fernando, Richette, Pascal, Southam, Siobhan, DiChiara, Matthew
Publicado no Arthritis Care Res (Hoboken) (2016)

Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study

Por Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Fung, Maple, Baumgartner, Scott, Perez-Ruiz, Fernando
Publicado no Arthritis Res Ther (2019)

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

Por Pérez-Ruiz, Fernando, Jansen, Tim, Tausche, Anne-Katrin, Juárez-Campo, Mónica, Gurunath, Ravichandra Karra, Richette, Pascal
Publicado no Drugs Context (2019)

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy

Por Perez-Ruiz, Fernando, Jansen, Tim L., Tausche, Anne-Kathrin, Richette, Pascal, Lioté, Frédéric, So, Alexander K., Stack, Austin
Publicado no Rheumatol Ther (2019)

Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality

Por Pérez Ruiz, Fernando, Richette, Pascal, Stack, Austin G, Karra Gurunath, Ravichandra, García de Yébenes, Ma Jesus, Carmona, Loreto
Publicado no RMD Open (2019)

Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study

Por Kumar A. U., Arun, Browne, Leonard D., Li, Xia, Adeeb, Fahd, Perez-Ruiz, Fernando, Fraser, Alexander D., Stack, Austin G.
Publicado no PLoS One (2018)

The burden of disease in Spain: results from the global burden of disease study 2010

Por Haro, Josep Maria, Tyrovolas, Stefanos, Garin, Noe, Diaz-Torne, Cesar, Carmona, Loreto, Sanchez-Riera, Lidia, Perez-Ruiz, Fernando, Murray, Christopher JL
Publicado no BMC Med (2014)

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

Por Dalbeth, Nicola, Jones, Graeme, Terkeltaub, Robert, Khanna, Dinesh, Kopicko, Jeff, Bhakta, Nihar, Adler, Scott, Fung, Maple, Storgard, Chris, Baumgartner, Scott, Perez‐Ruiz, Fernando
Publicado no Arthritis Rheumatol (2017)

Understanding the patient voice in gout: a quantitative study conducted in Europe

Por De Meulemeester, Marc, Mateus, Elsa, Wieberneit-Tolman, Hilda, Betteridge, Neil, Ireland, Lucy, Petersen, Gudula, Maske, Nina Jeanette, Jansen, Tim L, Perez-Ruiz, Fernando
Publicado no BJGP Open (2020)

Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice

Por Perez Ruiz, Fernando, Sanchez-Piedra, Carlos A., Sanchez-Costa, Jesus T., Andrés, Mariano, Diaz-Torne, Cesar, Jimenez-Palop, Mercedes, De Miguel, Eugenio, Moragues, Carmen, Sivera, Francisca
Publicado no Rheumatol Ther (2017)

Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group

Por Grainger, Rebecca, Dalbeth, Nicola, Keen, Helen, Durcan, Laura, Edwards, N. Lawrence, Perez-Ruiz, Fernando, Diaz-Torne, Cesar, Singh, Jasvinder A., Khanna, Dinesh, Simon, Lee S., Taylor, William J.
Publicado no J Rheumatol (2015)

Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence s...

Por Cohen, Stanley, Genovese, Mark C, Choy, Ernest, Perez-Ruiz, Fernando, Matsumoto, Alan, Pavelka, Karel, Pablos, Jose L, Rizzo, Warren, Hrycaj, Pawel, Zhang, Nan, Shergy, William, Kaur, Primal
Publicado no Ann Rheum Dis (2017)